[go: up one dir, main page]

PL3004082T3 - Modulatory receptora cxcr7 - Google Patents

Modulatory receptora cxcr7

Info

Publication number
PL3004082T3
PL3004082T3 PL14730591T PL14730591T PL3004082T3 PL 3004082 T3 PL3004082 T3 PL 3004082T3 PL 14730591 T PL14730591 T PL 14730591T PL 14730591 T PL14730591 T PL 14730591T PL 3004082 T3 PL3004082 T3 PL 3004082T3
Authority
PL
Poland
Prior art keywords
receptor modulators
cxcr7 receptor
cxcr7
modulators
receptor
Prior art date
Application number
PL14730591T
Other languages
English (en)
Inventor
Heinz Fretz
Philippe Guerry
Thierry Kimmerlin
Francois Lehembre
Julien Pothier
Hervé Siendt
Anja Valdenaire
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of PL3004082T3 publication Critical patent/PL3004082T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
PL14730591T 2013-05-30 2014-05-28 Modulatory receptora cxcr7 PL3004082T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2013054478 2013-05-30
EP14730591.6A EP3004082B1 (en) 2013-05-30 2014-05-28 Cxcr7 receptor modulators
PCT/IB2014/061774 WO2014191929A1 (en) 2013-05-30 2014-05-28 Cxcr7 receptor modulators

Publications (1)

Publication Number Publication Date
PL3004082T3 true PL3004082T3 (pl) 2018-01-31

Family

ID=50943357

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14730591T PL3004082T3 (pl) 2013-05-30 2014-05-28 Modulatory receptora cxcr7

Country Status (30)

Country Link
US (1) US9920010B2 (pl)
EP (1) EP3004082B1 (pl)
JP (1) JP6393749B2 (pl)
KR (1) KR102302580B1 (pl)
CN (1) CN105263924B (pl)
AR (1) AR096490A1 (pl)
AU (1) AU2014272718B2 (pl)
BR (1) BR112015030095B1 (pl)
CA (1) CA2912133C (pl)
CL (1) CL2015003470A1 (pl)
CY (1) CY1119537T1 (pl)
DK (1) DK3004082T3 (pl)
EA (1) EA028604B1 (pl)
ES (1) ES2645470T3 (pl)
HR (1) HRP20171597T1 (pl)
HU (1) HUE036649T2 (pl)
IL (1) IL242782B (pl)
LT (1) LT3004082T (pl)
MA (1) MA38679B1 (pl)
MX (1) MX364104B (pl)
MY (1) MY173564A (pl)
NO (1) NO3004082T3 (pl)
PH (1) PH12015502632A1 (pl)
PL (1) PL3004082T3 (pl)
PT (1) PT3004082T (pl)
SG (1) SG11201509057UA (pl)
SI (1) SI3004082T1 (pl)
TW (1) TWI640510B (pl)
UA (1) UA118562C2 (pl)
WO (1) WO2014191929A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
CA2963447A1 (en) 2014-12-01 2016-06-09 Actelion Pharmaceuticals Ltd Cxcr7 receptor modulators
US20170112831A1 (en) * 2015-10-23 2017-04-27 James MERRITT Use of ccr1 antagonists as a treatment for tumors of the central nervous system
SI3798217T1 (sl) * 2016-07-28 2023-05-31 Idorsia Pharmaceuticals Ltd Piperidinski modulatorji cxcr7 receptorja
PE20191811A1 (es) 2017-05-18 2019-12-26 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
PE20191814A1 (es) 2017-05-18 2019-12-27 Idorsia Pharmaceuticals Ltd Derivados de pirimidina como moduladores del receptor de pge2
RS65594B1 (sr) 2018-01-26 2024-06-28 Idorsia Pharmaceuticals Ltd Kristalni oblici antagonista cxcr7 receptora (1-pirimidin-2-il-ciklopropil)-amida (3s,4s)-1-ciklopropilmetil-4-{[5-(2,4-difluoro-fenil)-izoksazol-3-karbonil]-amino}-piperidin-3-karboksilne kiseline

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896170A (en) 1969-02-26 1975-07-22 American Home Prod Intermediates for the preparation of 1,3-dihydro-2h-1, -benzodiazepin-2-ones
IL137720A0 (en) 1998-02-18 2001-10-31 Neurosearch As Compounds and their use as positive ampa receptor modulators
GB9816984D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
JP2004515494A (ja) 2000-12-07 2004-05-27 アストラゼネカ・アクチエボラーグ 治療剤
DE60327106D1 (de) * 2002-12-20 2009-05-20 Chemocentryx Inc Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
DK1954274T3 (da) * 2005-11-10 2011-01-31 Chemocentryx Inc Substituerede quinoloner og fremgangsmåder til anvendelse
WO2009076404A1 (en) 2007-12-10 2009-06-18 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
CA2963447A1 (en) 2014-12-01 2016-06-09 Actelion Pharmaceuticals Ltd Cxcr7 receptor modulators

Also Published As

Publication number Publication date
SG11201509057UA (en) 2015-12-30
AU2014272718B2 (en) 2018-06-28
US20160107997A1 (en) 2016-04-21
US9920010B2 (en) 2018-03-20
DK3004082T3 (en) 2017-10-02
IL242782B (en) 2019-06-30
HRP20171597T1 (hr) 2017-12-01
TW201529557A (zh) 2015-08-01
HK1223353A1 (en) 2017-07-28
MX364104B (es) 2019-04-12
WO2014191929A1 (en) 2014-12-04
PH12015502632B1 (en) 2016-03-07
MY173564A (en) 2020-02-04
ES2645470T3 (es) 2017-12-05
IL242782A0 (en) 2016-02-01
AU2014272718A1 (en) 2016-01-21
CA2912133A1 (en) 2014-12-04
MA38679A1 (fr) 2018-07-31
AR096490A1 (es) 2016-01-13
KR20160013197A (ko) 2016-02-03
NO3004082T3 (pl) 2017-12-30
EA028604B1 (ru) 2017-12-29
TWI640510B (zh) 2018-11-11
CN105263924B (zh) 2018-10-19
EA201501163A1 (ru) 2016-06-30
EP3004082A1 (en) 2016-04-13
BR112015030095B1 (pt) 2023-02-28
CA2912133C (en) 2021-06-22
JP2016520120A (ja) 2016-07-11
CL2015003470A1 (es) 2016-06-17
EP3004082B1 (en) 2017-08-02
MX2015016429A (es) 2016-03-01
NZ715530A (en) 2020-12-18
KR102302580B1 (ko) 2021-09-15
CN105263924A (zh) 2016-01-20
LT3004082T (lt) 2017-10-25
MA38679B1 (fr) 2019-12-31
JP6393749B2 (ja) 2018-09-19
SI3004082T1 (sl) 2017-11-30
PH12015502632A1 (en) 2016-03-07
PT3004082T (pt) 2017-11-13
HUE036649T2 (hu) 2018-07-30
CY1119537T1 (el) 2018-03-07
UA118562C2 (uk) 2019-02-11
BR112015030095A2 (pt) 2022-07-12

Similar Documents

Publication Publication Date Title
IL244784A0 (en) chimeric antigen receptor
GB201213700D0 (en) Receptor antagnists II
EP3008056B8 (en) Novel glp-1 receptor modulators
IL240404A0 (en) link means
IL242782B (en) cxcr7 receptor modulators
IL235557A0 (en) Modulators of 17 gpr receptors
ME02984B (me) Vezujući sklop
GB201223053D0 (en) Receptor
IL243730A0 (en) Vasopressin-2 receptor agonists
SG11201510197RA (en) Connecting Mechanism
GB201312010D0 (en) Receptor Agonists
GB201312727D0 (en) Modulators
AU5069P (en) Alegnuflor704 Mandevilla hybrida
GB201318298D0 (en) Modulators
GB201317988D0 (en) Modulators
GB201304473D0 (en) Modulators
AU2013046V (en) Alegnuflor999 Mandevilla hybrida
AU2013045V (en) Alegnuf811 Mandevilla hybrida
GB201304115D0 (en) Fusion ploypeptide
GB201319478D0 (en) Dropper flopper
GB201309812D0 (en) MK-V fusion system
GB201323054D0 (en) No details
GB201307978D0 (en) No details